author-photo

Cassandra J. Vandenberg

Walter and Eliza Hall Institute of Medical Research
University of Melbourne

50

Papers

2938

Citations

Citation Trend

Filter By

Papers (30) Sort By

Journal Conference Others

Abstract 1074: Improving efficacy of microtubule inhibitors in the treatment of high-grade serous ovarian cancer and ovarian carcinosarcoma

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
CHK2 inhibition provides a strategy to suppress hematological toxicity from PARP inhibitors.

2021 Molecular Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
Chaperone-mediated protein degradation (CHAMP): A novel technology for tumor-targeted protein degradation.

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract PO021: Developing pre-clinical models of uterine leiomyosarcoma

2021
Show All
- Source
- Cite
- Save
Citations (0)
Improving efficacy of microtubule inhibitors in the treatment of high-grade serous ovarian cancer and ovarian carcinosarcoma.

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 2057: BRCA1 D11q isoform expression impacts PARP inhibitor responses in high grade serous ovarian carcinoma patient derived xenografts

2021
Show All
- Source
- Cite
- Save
Citations (0)
Ovarian carcinosarcoma genomics and pre-clinical models highlight the N-MYC pathway as a key driver and susceptibility to EMT-targeting therapy

2020 bioRxiv
Show All
- Source
- Cite
- Save
Citations (0)
Glucagonoma Masquerading as a Mucinous Cancer of the Ovary: Lessons from Cell Biology

2020
Show All
- Source
- Cite
- Save
Citations (0)
Development and Survival of MYC-driven Lymphomas Requires MYC-Antagonist MNT to Curb MYC-induced Apoptosis

2020 Blood
Show All
- Source
- Cite
- Save
Citations (12)
DNA repair processes are critical mediators of p53-dependent tumor suppression

2018 Nature Medicine
Show All
- Source
- Cite
- Save
Citations (63)